Search Saint Luke's

U.S. News & World Report shares results of a new study finding heart disease has plagued humanity for centuries.

Weight-loss drugs like Wegovy can improve symptoms in heart failure patients, new research led by Saint Luke's Mid America Heart Institute shows.

For people struggling with both diabetes and a common type of heart failure, the weight-loss drug Wegovy may do more for their health than help them shed pounds, new research suggests.

Weight-loss drug Wegovy (semaglutide) and its diabetes-focused cousin, Ozempic, have already upended the treatment of both obesity and diabetes, with sales of both drugs skyrocketing.

After ending up in the hospital with a stress-induced heart issue, Louise stayed optimistic and made lifestyle changes to turn her health around.

The University of Missouri–Kansas City (UMKC) School of Medicine opened in 1971 as the result of more than a decade of community efforts to establish a medical school in Kansas City, Missouri.

When she needed a heart transplant, she choose Saint Luke’s Mid America Heart Institute. A year later, Jenna’s feeling healthy and strong and advocating for improvements to medical devices for women.

Opt in for email 

Hypertension

The Global Paradise® System US Post Approval Study

USA Today talked to Dr. Paul Chan about disparities found when analyzing the effectiveness of bystander CPR for cardiac arrest.